Nuvectra Corp. (fka NVTRQ)

[joseytheoutlawwales]

Again, agree across the board.

It gets even more interesting if the buyout valuation climbs into the 200s.

Organically, prior to the Milestone delivery delays (both Virtis and MRI), we hit $20+. Which at that time, per OS, was approx $300 million market cap.

The institutions holding certainly thought the value was not only appropriate, but still not at its potential, given the fact they continued to increase holdings. (black rock really the main negative seller I know of).

Nothing in the company, hardware, software, has changed to the negative. Virtis will be approved. Full body MRI WAS approved in Europe, FDA pending, and will be approved.

I still think $200 million plus is still very much in play— despite the current market belief that nuvectra is only worth $3.5 million.

But time will tell!
My little sons college account will love NVTR selling for that higher value.